Skip to content

T +27 (0)21 900 6277
E reception@haemalife.co.za

A 4G Riverside View Chambers
Netcare Kuils River Hospital
33 Van Riebeeck Road
Kuils River
7580


Services We Offer

Therapies

Treatments used in cancer includes chemotherapy, radiotherapy, immuno- therapies, targeted therapies, or a combination of these. These drugs work in different mechanisms to destroy cancer cells. Effectiveness of treatment not only depends on the stage of cancer, but on various other factors as well. Side-effects are dependent on the intensity of the treatment, but also on the specific drugs used. Some treatments, for example chemotherapy, destroys cancer cells, but may also affect other healthy cells in the body. Most side-effects of the treatment will go away a few weeks after treatment finishes.

Bone Marrow Transplant

A bone marrow transplant is a medical procedure that is performed in order to replace the bone marrow that has been damaged due to disease or chemotherapy. To do this, we need to harvest cells either from the patient’s own body, or from a donor. The harvested stem cells are then transplanted into the patient’s body via an IV line, and they then travel to the bone marrow where they produce new blood cells and promote growth of new marrow. The patient will receive chemotherapy before the transplant and will need to stay in isolation at the hospital for 3 to 6 weeks after the transplant while their bone marrow recovers and starts to produce blood cells again.

Support services

Being diagnosed with any form of cancer is an incredibly scary thing to experience. Whether it is yourself or a loved one, your life is about to change.

We have a social worker on our team that is here to offer support services to patients and their loved ones before, during, and after treatment. Support services include individual counselling, family counselling, facilitating family meetings, assisting parents in talking to their children about cancer, assisting patients and loved ones with disability claims or letters to schools or work, or referrals to community resources.

It is important to know that you are not alone on this journey and that there is support available to you and your loved ones. Feel free to contact our social worker, Mariska, at any point of your journey for support.

Medical care

You will receive the best possible level of medical care when you step into our practice. The doctors will make sure you are well consulted, and then our team of nurses will provide you with the treatment as prescribed.

While you receive your treatment, whether it is anti-cancer treatment, intravenous anti-nausea medication or a blood transfusions, the Haemalife team will do all we can to make you feel as comfortable and cared for as possible.

Pharmacy

Our in-house pharmacy forms the logistical and clinical backbone of the practice.
We manage all aspects of oncology and haematology medicine supply — from patient-specific ordering, cold-chain coordination and stock control to dispensing and treatment support.

The team ensures accuracy, safety, and compliance in every step of the medication process, working closely with doctors, nursing staff and funders to guarantee seamless treatment delivery.

Our pharmacists also provide ongoing patient counselling and education, reinforcing our commitment to safe, personalised cancer care.

Clinical Trials

The Clinical Trials Department supports the advancement of evidence-based oncology and haematology care through the conduct of ethically approved, sponsor-funded studies.

Our pharmacy and clinical teams manage the full trial workflow — from site setup, regulatory readiness, and investigational product handling to patient enrolment and protocol adherence.

We partner with leading global sponsors to make innovative treatments accessible to our patients while maintaining the highest standards of Good Clinical Practice (GCP), integrity, and patient safety.

Allied Health Services

Physiotherapy:

Our patients will be seen in hospital by Liana Bence. She will assess your mobility and help you do exercises to keep in shape during your hospital stay. Her goal is to keep you active and mobile, to ensure optimal healing. She will do exercises with the patients to prevent complications due to immobility and to prevent muscle atrophy.

Dietetics:

Stephanie is a dietician that will visit you in hospital during your treatment. She will ensure that you are eating enough and getting in the right amount of calories. She will arrange supplements and meal replacements if necessary, and she will guide you on what you should be eating to facilitate optimal healing.

"All the staff are super friendly and professional and there is a happy atmosphere. The illness that I have is tough to deal with and Haemalife have helped me to get back some of my old life. Thank you Haemalife Doctors and Staff"
"Ek is voorwaar bevoorreg om hier by Haemalife te kan wees. Ek wil net op hierdie stadium vir julle dankie sê wat die pad sover met ons geloop het. Elkeen van julle het 'n groot impak op my lewe gemaak. Die pad vorentoe loop ek in geloof met julle Haemalife praktyk en dankie vir elkeen se bydrae in my behandeling. Dis met 'n diepe dankbaarheid wat ek julle almal in my hart koester."

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by

CLL

Chronic Lymphocytic Leukemia (CLL) is a slow-growing cancer of B-lymphocytes, a type of white blood cell. In CLL, abnormal B-cells accumulate in the blood, bone marrow, and lymphoid tissues, often crowding out healthy cells and weakening the immune system.

Diagnosis is made through blood tests showing a high number of mature-looking lymphocytes, flow cytometry to confirm their identity, and sometimes bone marrow biopsy. Genetic testing helps predict disease course and guide treatment.

Types of CLL are classified mainly by genetic features (e.g., deletions of 17p, 13q, or mutations like TP53) and immunoglobulin heavy chain (IGHV) mutation status, which influence prognosis and therapy choice.

Treatment options depend on symptoms, disease progression, and risk factors. Many patients are initially monitored without treatment (“watch and wait”). When therapy is needed, options include targeted therapies (BTK inhibitors, BCL2 inhibitors), chemotherapy, monoclonal antibodies, and in select cases, stem cell transplantation. Supportive care focuses on managing infections and other complications.

MYELOMA

Multiple Myeloma (MM) is a cancer of plasma cells, a type of white blood cell that produces antibodies. In MM, abnormal plasma cells accumulate in the bone marrow, crowding out healthy cells and producing defective antibodies, which can cause organ damage.

Diagnosis involves blood tests (showing abnormal proteins or anemia), urine tests (detecting excess light chains), and a bone marrow biopsy. Imaging like X-rays, MRI, or PET/CT scans can detect bone lesions. Additional tests identify genetic changes that affect prognosis.

Types of Myeloma are often classified based on the type of abnormal protein produced (IgG, IgA, light-chain, etc.) and genetic features of the plasma cells. Smoldering (asymptomatic) myeloma is an early, slow-growing form.

Treatment options depend on age, health, and disease stage. Common approaches include chemotherapy, targeted therapies (like proteasome inhibitors or immunomodulators), immunotherapy (monoclonal antibodies), stem cell transplantation, and supportive care to manage bone disease, anemia, or kidney problems.

ALL

Acute Lymphoblastic Leukemia (ALL) is a fast-growing cancer of the blood and bone marrow in which immature lymphoid cells (B or T lymphocytes) multiply uncontrollably, crowding out normal blood cells and impairing immune function.

Diagnosis involves blood tests showing abnormal lymphoblasts, followed by a bone marrow biopsy. Immunophenotyping, cytogenetic, and molecular testing are used to confirm the diagnosis, classify the subtype, and assess prognosis.

Types of ALL are classified based on the lymphocyte involved (B-cell or T-cell ALL) and specific genetic abnormalities. Certain subtypes, such as Philadelphia chromosome–positive ALL, have important treatment implications.

Treatment options depend on age, risk factors, and genetic findings. Therapy typically includes multi-phase chemotherapy, targeted therapies (such as tyrosine kinase inhibitors), immunotherapy (including monoclonal antibodies or CAR T-cell therapy), and in some cases stem cell transplantation. Supportive care is essential throughout treatment.

AML

Acute Myeloid Leukemia (AML) is a fast-growing cancer of the blood and bone marrow in which abnormal myeloid cells multiply and crowd out normal blood cells, leading to anemia, infections, and bleeding.

Diagnosis is made through blood tests showing abnormal cells, followed by a bone marrow biopsy. Additional tests such as cytogenetic, molecular, and immunophenotyping studies help confirm AML and guide treatment.

Types of AML are classified based on cell appearance and genetic changes. Major systems include the WHO and FAB classifications. Subtypes are defined by specific chromosome or gene abnormalities, such as acute promyelocytic leukemia (APL), which requires specialized therapy.

Treatment options depend on patient age, health, and AML subtype. They may include intensive chemotherapy, targeted therapies (such as FLT3 or IDH inhibitors), immunotherapy, and stem cell (bone marrow) transplantation. Supportive care, including antibiotics and blood transfusions, is also essential.